Remobilization does not fully restore immobilization induced articular cartilage atrophy.
The recovery of articular cartilage from immobilization induced atrophy was studied. The right hind limbs of 29-week-old beagle dogs were immobilized for 11 weeks and then remobilized for 50 weeks. Cartilage from the immobilized knee was compared with tissue from age matched control animals. After the immobilization period, uncalcified articular cartilage glycosaminoglycan concentration was reduced by 20% to 23%, the reduction being largest (44%) in the superficial zone. The collagen fibril network showed no significant changes, but the amount of collagen crosslinks was reduced (13.5%) during immobilization. After remobilization, glycosaminoglycan concentration was restored at most sites, except for in the upper parts of uncalcified cartilage in the medial femoral and tibial condyles (9% to 17% less glycosaminoglycans than in controls). The incorporation of 35SO4 was not changed, and remobilization also did not alter the birefringence of collagen fibrils. Remobilization restored the proportion of collagen crosslinks to the control level. The changes induced by joint unloading were reversible at most sites investigated, but full restoration of articular cartilage glycosaminoglycan concentration was not obtained in all sites, even after remobilization for 50 weeks. This suggests that lengthy immobilization of a joint can cause long lasting articular cartilage proteoglycan alterations at the same time as collagen organization remains largely unchanged. Because proteoglycans exert strong influence on the biomechanical properties of cartilage, lengthy immobilization may jeopardize the well being of articular cartilage.
Haapala
J
J
Department of Surgery, Kuopio University Hospital, Finland.
Arokoski
J P
JP
Hyttinen
M M
MM
Lammi
M
M
Tammi
M
M
Kovanen
V
V
Helminen
H J
HJ
Kiviranta
I
I
D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001284:Atrophy; D001696:Biomechanical Phenomena; D002358:Cartilage, Articular / Q000737:chemistry / Q000473:pathology* / Q000503:physiopathology; D016022:Case-Control Studies; D003094:Collagen / Q000032:analysis / Q000648:ultrastructure; D004396:Coloring Agents; D004285:Dogs; D005260:Female; D005269:Femur / Q000737:chemistry / Q000473:pathology; D006025:Glycosaminoglycans / Q000032:analysis; D006614:Hindlimb; D006909:Hydroxyproline / Q000032:analysis; D007103:Immobilization; D008859:Microscopy, Polarization; D015591:Microspectrophotometry; D009068:Movement; D010619:Phenazines; D011509:Proteoglycans / Q000032:analysis; D019275:Radiopharmaceuticals; D020127:Recovery of Function; D013462:Sulfur Radioisotopes; D013977:Tibia / Q000737:chemistry / Q000473:pathology; D016474:Weight-Bearing / Q000502:physiology
D000596:Amino Acids; D004396:Coloring Agents; D006025:Glycosaminoglycans; D010619:Phenazines; D011509:Proteoglycans; D019275:Radiopharmaceuticals; D013462:Sulfur Radioisotopes; C015484:pyridinoline; D003094:Collagen; D006909:Hydroxyproline; C009195:safranine T